Additional inhibitor can help anti-VEGF therapy overcome resistance in deadly brain cancer: Study identifies target, shows proof-of-concept in mice

Adding another inhibitor to therapies that cut off a tumor's access to blood vessels could be the key to helping those therapies overcome resistance in glioblastoma, a deadly form of brain cancer.

  • 0 Likes

  • 0 Comments

See posts by others with similar interest